Literature DB >> 4281167

Comparative studies on the in vivo distribution pattern of dibromodulcitol and diepoxydulcitol.

G Pethes.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4281167     DOI: 10.1007/bf00284339

Source DB:  PubMed          Journal:  Z Krebsforsch Klin Onkol Cancer Res Clin Oncol        ISSN: 0084-5353


× No keyword cloud information.
  10 in total

1.  THE FORMATION OF EPOXIDES FROM CYTOTOXIC POLYOL METHANESULPHONATES UNDER PHYSIOLOGICAL CONDITIONS.

Authors:  W DAVIS; W C ROSS
Journal:  Biochem Pharmacol       Date:  1963-08       Impact factor: 5.858

2.  [Correlation of the differences of biological effects and distribution parameters of 1,6-dibromohexitols].

Authors:  L Institóris; E Dzurillay; J H Sebestyén; A Jeney; G Pethes
Journal:  Z Krebsforsch       Date:  1971

3.  Clinical and pharmacologic experience with dibromodulcitol (NSC-104800). A new antitumor agent.

Authors:  C Sellei; S Eckhardt; I P Horváth; J Kralovánszky; L Institóris
Journal:  Cancer Chemother Rep       Date:  1969-12

4.  Phase I study of dibromodulcitol (NSC-104800).

Authors:  N C Andrews; A J Weiss; F J Ansfield; D B Rochlin; J H Mason
Journal:  Cancer Chemother Rep       Date:  1971-02

5.  Toxicity, haematological effects and anti-tumour activity of epoxides derived from disubstituted hexitols. Mode of action of mannitol myleran and dibromomannitol.

Authors:  L A Elson; M Jarman; W C Ross
Journal:  Eur J Cancer       Date:  1968-12       Impact factor: 9.162

6.  Investigation into the correlation of cytostatic activity with the in vitro diepoxide formation on some terminally substituted hexitols.

Authors:  L Institóris; L Németh; S Somfai; F Gál; I Hercsei; S Zaka; B Kellner
Journal:  Neoplasma       Date:  1970       Impact factor: 2.575

7.  Pharmacology of 1,6-Dibromo-1,6-dideoxy-dulcitol and its Cytostatic effect on transplantable tumours.

Authors:  B Kellner; L Németh; J Sugár; E Gáti; I Pályi; L Döbrössy
Journal:  Arzneimittelforschung       Date:  1967-08

8.  Dibromodulcitol (NSC-104800)--clinical brochure.

Authors:  S K Carter
Journal:  Cancer Chemother Rep 3       Date:  1968-12

9.  1,6-Dibromo-1,6-dideoxy-dulcitol: a new antitumoral agent.

Authors:  B Kellner; L Németh; P Horváth; L Insitóris
Journal:  Nature       Date:  1967-01-28       Impact factor: 49.962

10.  Metabolic pathway of cytostatic dibromohexitols.

Authors:  L Institóris; I P Horváth; G Pethes; S Eckhardt
Journal:  Cancer Chemother Rep       Date:  1967-09
  10 in total
  2 in total

Review 1.  Do anticancer agents reach the tumor target in the human brain?

Authors:  M G Donelli; M Zucchetti; M D'Incalci
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

2.  Chemotherapeutic approaches to brain tumors. Experimental observations with dianhydrogalactitol and dibromodulcitol.

Authors:  V A Levin; K T Wheeler
Journal:  Cancer Chemother Pharmacol       Date:  1982       Impact factor: 3.333

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.